Diagnostics & Research
The Diagnostics & Research industry has a total of 50 stocks, with a combined market cap of $789.9 billion, total revenue of $166.47 billion and a weighted average PE ratio of 52.82.
Market Cap
789.9B
Revenue
166.47B
Profits
14.96B
PE Ratio
52.82
Profit Margin
8.98%
Dividend Yield
0.18%
50 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | TMO | Thermo Fisher Scientific Inc. | 218.19B | 0.28% | 466,139 | 43.74B |
| 2 | DHR | Danaher Corporation | 162.69B | -0.22% | 1,140,713 | 24.27B |
| 3 | IDXX | IDEXX Laboratories, Inc. | 54.98B | 0.04% | 204,146 | 4.17B |
| 4 | A | Agilent Technologies, Inc. | 39.23B | 0.05% | 739,338 | 6.95B |
| 5 | IQV | IQVIA Holdings Inc. | 38.64B | 0.40% | 426,072 | 15.90B |
| 6 | NTRA | Natera, Inc. | 32.33B | -0.76% | 410,923 | 2.12B |
| 7 | MTD | Mettler-Toledo International Inc. | 29.01B | 0.21% | 39,636 | 3.94B |
| 8 | WAT | Waters Corporation | 22.98B | 0.32% | 231,488 | 3.11B |
| 9 | LH | Labcorp Holdings Inc. | 21.05B | -0.22% | 248,310 | 13.77B |
| 10 | ILMN | Illumina, Inc. | 20.62B | -0.27% | 487,509 | 4.29B |
| 11 | DGX | Quest Diagnostics Incorporated | 19.57B | 0.01% | 402,681 | 10.85B |
| 12 | EXAS | Exact Sciences Corporation | 19.27B | 0.03% | 1,251,165 | 3.08B |
| 13 | MEDP | Medpace Holdings, Inc. | 15.99B | -0.75% | 161,455 | 2.36B |
| 14 | ICLR | ICON Public Limited Company | 13.96B | -0.46% | 245,337 | 8.10B |
| 15 | GH | Guardant Health, Inc. | 13.27B | 0.59% | 1,042,359 | 902.57M |
| 16 | RVTY | Revvity, Inc. | 10.97B | -0.03% | 557,143 | 2.81B |
| 17 | CRL | Charles River Laboratories International, Inc. | 10.02B | 0.25% | 293,261 | 4.02B |
| 18 | QGEN | Qiagen N.V. | 9.84B | -0.24% | 719,623 | 2.07B |
| 19 | RDNT | RadNet, Inc. | 5.65B | 0.29% | 376,473 | 1.97B |
| 20 | SHC | Sotera Health Company | 5.03B | - | 902,837 | 1.15B |
| 21 | BLLN | BillionToOne, Inc. | 4.09B | 3.43% | 84,469 | 254.14M |
| 22 | WGS | GeneDx Holdings Corp. | 3.87B | -1.69% | 214,401 | 402.19M |
| 23 | GRAL | GRAIL, Inc. | 3.57B | -0.29% | 498,506 | 141.83M |
| 24 | VCYT | Veracyte, Inc. | 3.36B | -0.65% | 382,995 | 495.14M |
| 25 | TWST | Twist Bioscience Corporation | 2.02B | -1.58% | 680,900 | 376.57M |
| 26 | NEO | NeoGenomics, Inc. | 1.59B | -0.16% | 1,188,410 | 709.16M |
| 27 | NEOG | Neogen Corporation | 1.55B | -0.14% | 1,754,161 | 886.89M |
| 28 | CSTL | Castle Biosciences, Inc. | 1.15B | -1.73% | 183,714 | 343.53M |
| 29 | CDNA | CareDx, Inc | 1.00B | -1.27% | 291,624 | 358.00M |
| 30 | OPK | OPKO Health, Inc. | 990.33M | -0.77% | 2,296,762 | 642.07M |
| 31 | FLGT | Fulgent Genetics, Inc. | 825.98M | -1.07% | 133,794 | 315.55M |
| 32 | PSNL | Personalis, Inc. | 722.87M | -3.21% | 454,756 | 69.10M |
| 33 | MYGN | Myriad Genetics, Inc. | 604.02M | -1.07% | 757,365 | 825.30M |
| 34 | PRE | Prenetics Global Limited | 284.06M | -0.18% | 49,147 | 77.08M |
| 35 | BNR | Burning Rock Biotech Limited | 227.98M | -0.17% | 18,140 | 75.75M |
| 36 | IMDX | Insight Molecular Diagnostics Inc. | 182.59M | 9.45% | 71,758 | 4.40M |
| 37 | MDXH | MDxHealth SA | 168.79M | -1.73% | 42,253 | 103.07M |
| 38 | XGN | Exagen Inc. | 138.92M | -0.97% | 227,180 | 63.60M |
| 39 | FONR | FONAR Corporation | 94.67M | -0.55% | 22,526 | 105.43M |
| 40 | BDSX | Biodesix, Inc. | 54.26M | -0.87% | 34,358 | 80.17M |
| 41 | PRPO | Precipio, Inc. | 41.63M | -0.53% | 5,600 | 22.80M |
| 42 | NOTV | Inotiv, Inc. | 20.94M | -4.57% | 620,383 | 513.02M |
| 43 | MYNZ | Mainz Biomed N.V. | 10.90M | 8.55% | 338,509 | 659.94K |
| 44 | MBAI | Check-Cap Ltd. | 9.83M | -6.15% | 22,119 | - |
| 45 | ADVB | Advanced Biomed Inc. | 7.93M | -2.24% | 153,196 | - |
| 46 | NDRA | ENDRA Life Sciences Inc. | 5.93M | -0.39% | 10,014 | - |
| 47 | BIAF | bioAffinity Technologies, Inc. | 5.26M | -4.88% | 115,245 | 6.78M |
| 48 | ISPC | iSpecimen Inc. | 3.73M | -1.44% | 262,710 | 3.35M |
| 49 | XWEL | XWELL, Inc. | 3.56M | -1.90% | 34,647 | 29.52M |
| 50 | PRPH | ProPhase Labs, Inc. | 2.40M | -15.45% | 1,299,800 | 5.06M |